News | April 22, 2024
Biocon receives approval from SAHPRA for Tacrolimus Capsule
Tacrolimus is an immunosuppressant used in the treatment of organ transplant patients
Tacrolimus is an immunosuppressant used in the treatment of organ transplant patients
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Strides is the first Indian company to get approval for the product.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)